Editorial Nanozyme: New Horizons for Cancer Therapy
Nanozyme for Cancer Therapy
Abstract
Nanocatalytic medicine has attracted considerable
interest in recent years as it is progressively being
explored in cancer diagnosis and treatment,
inflammation, infectious diseases, and degenerative
disease.[1-4] The concept of nanocatalytic medicine
is centered on exploiting nanocatalysts to resolve
medical problems.[1,5,6] Catalytic therapies have
greatly benefited the growing field of nanomedicine
as they have provided effective strategies for tumor
therapy, antibacterial therapy, and anti-inflammatory
therapy.[1,2
References
Huo M, Wang L, Chen Y, Shi J. Tumor-selective catalytic
nanomedicine by nanocatalyst delivery. Nat Commun
;8:357.
Xu K, Cui Y, Guan B, Qin L, Feng D, Abuduwayiti A, et al.
Nanozymes with biomimetically designed properties for
cancer treatment. Nanoscale 2024;16:7786.
Li Q, Liu Y, Dai X, Jiang W, Zhao H. Nanozymes regulateredox homeostasis in ros-related inflammation. Front
Chem 2021;9:740607.
Qin T, Ma R, Yin Y, Miao X, Chen S, Fan K, et al. Catalytic
inactivation of influenza virus by iron oxide nanozyme.
Theranostics 2019;9:6920.
Yang B, Chen Y, Shi J. Reactive oxygen species (ROS)-
based nanomedicine. Chem Rev 2019;11:4881.
Lin H, Chen Y, Shi J. Nanoparticle-triggered in situ
catalytic chemical reactions for tumour-specific therapy.
Chem Soc Rev 2018;4:1938.
Yang B, Chen Y, Shi J. Nanocatalytic medicine. Adv
Mater 2019;3:1901778.
Wang Z, Zhang Y, Ju E, Liu Z, Cao F, Chen Z, et al.
Biomimetic nanoflowers by self-assembly of nanozymes
to induce intracellular oxidative damage against hypoxic
tumors. Nat Commun 2018;9:3334.
Lu X, Gao S, Lin H, Yu L, Han Y, Zhu P, et al. Bioinspired
copper single-atom catalysts for tumor parallel catalytic
therapy. Adv Mater 2020;32:2002246.
Zhao M, Zhang N, Yang R, Chen D, Zhao Y. Which is
better for nanomedicines: Nanocatalysts or single-atom
catalysts? Adv Healthc Mater 2021;10:2001897.
Fei H, Dong J, Feng Y, Allen CS, Wan C, Volosskiy B,
et al. General synthesis and definitive structural
identification of MN4C4 single-atom catalysts with
tunable electrocatalytic activities. Nat Catal 2018;1:63.
Ai Y, Hu Z, Liang X, Sun H, Xin H, Liang Q. Recent
advances in nanozymes: From matters to bioapplications.
Adv Funct Mater 2022;32:2110432.
Chen T, Chu Q, Li M, Han G, Li X. Fe3O4@Pt nanoparticles
to enable combinational electrodynamic/chemodynamic
therapy. J Nanobiotechnol 2021;19:206.
Zandieh M, Liu J. Nanozymes: Definition, activity, and
mechanisms. Adv Mater 2023;36 2211041.
Ghorbani M, Izadi Z, Jafari S, Casals E, Rezaei F,
Aliabadi A, et al. Preclinical studies conducted on
nanozyme antioxidants: Shortcomings and challenges
based on US FDA regulations. Nanomedicine (Lond)
;16:1133.
Published
Issue
Section
License
Copyright (c) 2025 MMJ - A Journal by MIMER Medical College, Pune, India
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
